State-Level R&D Tax Credits: A Firm-Level Analysis

B.E. Journal of Economic Analysis and Policy

Volumn 5, Issue 1, 2005, Pages

  Paff, Lolita A ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

R D; Research Policy; Tax Credit

Indexed keywords

EID: 85117439348     PISSN: None     EISSN: 19351682     Source Type: Journal    
DOI: 10.1515/1538-0653.1272     Document Type: Article

References (32)

1. American Association for the Advancement of Science 1999 http://www.aaas.org/spp/dspp/cstc/regrep/california/highlights.htm
2. "Biotechnology industry seeks creative financing solutions," March 8, 1999, Chemical Market Reporter, 255(10): 1.
3. Bloom, N., R. Griffith, J. Van Reenen. 2002. "Do R&D Tax Credits Work? Evidence from a panel of countries 1979-1997," Journal of Public Economics, 85(1): 1-31.
4. Bushee, B. 1998. "The Influence of Institutional Investors on Myopic R&D Investment Behavior," Accounting Review, 73: 305-333.
5. California Commerce Agency. 2004. http://commerce.ca.gov
6. California Franchise Tax Board. 1999. http://www.ftb.ca.gov/index.html
7. California Life Sciences Action Plan: Taking Action for Tomorrow. 2004. http://www.larta.org/lavox/articlelinks/2004/040524-plan.asp
8. Collaborative Economics. 1997. Index of the Massachusetts Innovation Economy. Massachusetts Technology Collaborative, Westborough, MA.
9. Collaborative Economics. 2003. Index of the Massachusetts Innovation Economy. Massachusetts Technology Collaborative, Westborough, MA.
10. Commerce Clearing House Incorporated (CCH). 2000. www.cch.com
11. Compustat. 2000. Research Insight 7.6, Standard & Poor s. www.compustat.com
12. Cortright, J. and H. Mayer. 2002. Signs of Life: The Growth of Biotechnology Centers in the U.S., The Brookings Institution, Washington, DC.
13. "Cytokinetics Bucks Biotech Trend with Successful IPO," June 7, 2004, Corporate Financing Week, page 1.
14. "FINDING FUNDING: Small Biotech Firms Look to Big Pharma for Cash," June 11, 2004, The Business Journal, Phoenix AZ, 24(38): 29.
15. Hall, B. 1993. "R&D Tax Policy During the Eighties: Success or Failure?" Tax Policy and the Economy 7: 1-36.
16. Hall, B., J. Van Reenen. 2000. "How effective are fiscal incentives for R&D? A new review of the evidence. Research Policy 29(4-5): 449-469.
17. Hall, B., M. Wosinska. 1999. "Effectiveness of the California R&D Tax Credit," California Council on Science and Technology, Sacramento, California.
18. Himmelberg, C., B. Petersen. 1994. "R&D and Internal Finance: A Panel Study of Small Firms in High-Tech Industries." The Review of Economics and Statistics, 76:1, 38-51.
19. Hines, J.R. 1993. "On the Sensitivity of R&D to Delicate Tax Changes: The Behavior of U.S. Multinationals in the 1980s," in Alberto Giovanni, R.
20. Glenn Hubbard, and Joel Slemrod, eds. Studies in International Taxation, Chicago: University of Chicago Press, 149-187.
21. Hines, J.R. 1994. "No Place Like Home: Tax Incentives and the Location of R&D by American Multinationals," in James M. Poterba, ed. Tax Policy and the Economy, Volume 8, Cambridge, MA: MIT Press, 65-104.
22. Koga, T. 2003. "Firm size and R&D Tax Incentives," Technovation, 23: 643-648. KPMG. Corporate Tax Rate Surveys, 1994-1999.
23. "Loans, convertible debt are popular options for biotechs," October 31, 2003, The Boston Business Journal, 23(39): S8. Massachusetts Department of Revenue. 1999. http://www.dor.state.ma.us/
24. McCutchen, W.W. 1993. "Estimating the Impact of the R&D Tax Credit on Strategic Groups in the Pharmaceutical Industry," Research Policy, 22(4): 337-351.
25. National Science Foundation, Division of Science Resource Studies. 1997.
26. National Patterns of R&D Resources: 1996, NSF 96-333, Arlington, VA.
27. National Science Foundation, Division of Science Resource Studies. 1999.
28. National Patterns of R&D Resources: 1998, NSF 99-335, Arlington, VA.
29. National Science Foundation. 2000. Division of Science Resources Studies, Research and Development in Industry: 1998, NSF01-305, Arlington, VA.
30. Paff, L. 2004. "Does the alternate incremental credit affect firm R&D?" Technovation, 24: 41-52.
31. Watkins, T. and L. Paff. 2004. "A Test for R&D Complementarities in Biopharmaceutical and Software Industries Using R&D Tax Price Changes," Health and Bio-Pharmaceutical Economics Working Paper Series 2004-1, Martindale Center, College of Business and Economics, Lehigh University, Bethlehem, PA.
32. Zucker, L., M. Darby. 1999. "California s Inventive Activity: patent Indicators of Quantity, Quality and Organizational Origins." A report prepared for The California Council on Science and Technology, Sacramento, CA.